Novel anti-tumor drug (radiosensitizer)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novel anti-tumor drug (radiosensitizer), covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.